Filed Pursuant to Rule 424(b)(5)
Registration No. 333-237971
PROSPECTUS SUPPLEMENT
(To Prospectus dated May 1, 2020)
Up to $100 Million Maximum Aggregate Offering Price of Common Shares
SFL Corporation Ltd.
We have entered into an Amended and Restated At-the-Market Sales Agreement, or the Sales Agreement, with BTIG, LLC (“BTIG” or the “sales agent”) relating to our common shares, offered by this prospectus supplement and the accompanying base prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell common shares having an aggregate offering price of up to $100,000,000 from time to time through BTIG, as our sales agent.
The Sales Agreement amended and restated our At-The-Market Sales Agreement, dated May 13, 2020, with BTIG (the “Original Agreement”). Upon entry into the Sales Agreement we terminated our prior “at-the-market” program established in May 2020 pursuant to the Original Agreement. At the time of such termination, we had sold 11,388,275 of our common shares for an aggregate sales price of $91,252,246 under the Original Agreement and our prospectus supplement dated May 13, 2020, which provided for the sale of up to $100,000,000 of our common shares.
Sales of common shares, if any, will be made in sales deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act, including, without limitation, by means of ordinary brokers’ transactions on the New York Stock Exchange, or the NYSE, at market prices, in block transactions, or as otherwise agreed upon by the sales agent and us.
We will pay the sales agent a commission of 1.0% of the gross proceeds of all sales of common shares for a per share price of less than or equal to the daily volume weighted average price as reported by Bloomberg for such trading day (the “Daily VWAP”) and 1.25% of the gross proceeds of all sales of common shares for a per share price that are higher than the Daily VWAP. The net proceeds from any sales under this prospectus supplement will be used as described under “Use of Proceeds” in this prospectus supplement.
In connection with the sales of our common shares on our behalf, BTIG may be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation paid to BTIG may be deemed to be underwriting commissions or discounts. We have agreed in the Sales Agreement to provide indemnification and contribution to BTIG against certain liabilities, including liabilities under the Securities Act.
Under the terms of the Sales Agreement, we also may sell common shares to the sales agent as principal for its own account at a price agreed upon at the time of sale. If we sell common shares to the sales agent as principal, we will enter into a separate agreement with the sales agent, and we will describe this agreement in a separate prospectus supplement or pricing supplement.
The sales agent is not required to sell any specific number or dollar amount of our common shares, but will use commercially reasonable efforts, as our agent and subject to the terms of the Sales Agreement, to sell the common shares offered, as instructed by us. The offering of common shares pursuant to the Sales Agreement will terminate upon the earlier of (1) the sale of all of the common shares subject to the Sales Agreement or (2) the termination of the Sales Agreement by either the sales agent or us.
Our common shares are listed on the NYSE under the symbol “SFL.” On April 13, 2022, the last reported sale price of our common shares on the NYSE was $10.56 per share.
Investing in our common shares involves risks. You should carefully consider each of the factors described under “Risk Factors ” beginning on page S-4 of this prospectus supplement, on page 8 of the accompanying base prospectus and in the documents incorporated by reference into this prospectus supplement and the accompanying base prospectus, before you make any investment in our common shares.
Neither the U.S. Securities and Exchange Commission, or the Commission, nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
BTIG
Prospectus Supplement dated April 15, 2022